Cargando…
Evaluation of the Risk for Acute Kidney Injury in Adult Cystic Fibrosis Patients Receiving Concomitant Vancomycin and Tobramycin
Background The risk for acute kidney injury (AKI) has been associated with both tobramycin and vancomycin. Objective To determine whether the rate of drug therapy-related nephrotoxicity is greater in Cystic Fibrosis (CF) patients receiving concomitant vancomycin and tobramycin than patients receivin...
Autores principales: | Muirhead, Corinne, Lim, Jeong Y, Lapidus, Jodi, MacDonald, Kelvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986173/ https://www.ncbi.nlm.nih.gov/pubmed/29872606 http://dx.doi.org/10.7759/cureus.1912 |
Ejemplares similares
-
Identification and characterization of bacteria isolated from patients with cystic fibrosis in Jordan
por: Alshraiedeh, Nid’a, et al.
Publicado: (2022) -
Vancomycin Spacer-induced Hemolysis
por: Sudhakaran, Anuraj, et al.
Publicado: (2019) -
Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial
por: Gwee, Amanda, et al.
Publicado: (2018) -
Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients
por: Rafey, Abdur, et al.
Publicado: (2022) -
Etiology, Clinical, Radiological, and Microbiological Profile of Patients with Non-cystic Fibrosis Bronchiectasis at a Tertiary Care Hospital of Pakistan
por: Sharif, Nadia, et al.
Publicado: (2020)